Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2014 Publisher: Crawford Healthcare Ltd, Kind Edward Court, Kind Edward Road, Knutsford, Cheshire, WA16 0BE, United Kingdom
Zindaclin is indicated for the treatment of mild to moderate acne vulgaris.
Apply a thin film of Zindaclin once daily to the affected area. Patient response should be reviewed after 6-8 weeks of treatment and the duration of treatment should be limited to 12 weeks.
Zindaclin is not indicated for use in children below the age of 12 years.
Cutaneous use.
It is not expected that overdose would occur in normal use. Irritant dermatitis may occur when excessive quantities of Zindaclin are applied. The use of a suitable moisturiser may be of benefit in these cases. In subsequent applications a thin film of Zindaclin should be applied in accordance with the dosage instructions (see section 4.2, Posology and method of administration).
2 years.
No special precautions for storage.
Zindaclin is packaged in 15g, 30g, 60g laminate tubes with a high-density polyethylene inner layer and a peelable membrane laminate seal covering the orifice. The tube is fitted with a white opaque polypropylene screw cap.
Not all pack sizes may be marketed.
No special requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
